Constarium
← Search

Omics · study · 2026

RNA-seq profiling of radioiodine-treated differentiated thyroid cancer cells reveals DDR pathway regulation during iodine tolerance

Listed in NCBI GEO

Aim: To investigate the role of ataxia-telangiectasia mutated (ATM) in thyroid cancer (TC) progression and radioactive iodine (RAI) resistance, exploring its potential as a therapeutic target.

Description

Methods

Single-cell RNA sequencing of 28 TC tumors / normal tissues traced ATM dynamics during dedifferentiation. Clinical validation used tissue microarrays (TMAs) on 89 RAI resistance (RAIR) and RAI-avid differentiated thyroid cancer (DTC) specimens. Preclinical models evaluated the synergy between the ATM inhibitor AZD1390 and RAI.

Read the rest (3 more)

Mechanistic studies employed RNA-seq, comet assays, cell cycle analysis, and AP site quantification. Results: scRNA-seq revealed progressive ATM upregulation during malignant progression, correlating with cell cycle dysregulation. TMAs confirmed elevated ATM expression in anaplastic thyroid cancer (ATC) vs. papillary thyroid cancer, PTC and RAIR tumors.

In vivo, AZD1390 + 131I synergistically suppressed tumor growth and enhanced apoptosis. RAI predominantly induced apurinic/apyrimidinic (AP) sites rather than double-strand breaks (DSBs). ATM inhibition disrupted base excision repair (BER) coordination and G2/M checkpoint control, forcing cells with unresolved AP sites into mitotic catastrophe.

Conclusion: ATM mediates RAIR in thyroid cancer by promoting AP site repair and inducing cell cycle arrest. Inhibiting ATM converts repairable damage into lethal DNA lesions, restoring RAI sensitivity, suggesting ATM as a therapeutic target for RAI-refractory thyroid cancer.

Links

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75% · RNA sequencing 75% · Sequencing 75% · Single-cell RNA sequencing 75%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE29716413 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[modality].local:modality:rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:sequencingenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[modality].local:modality:single-cell-rna-seqenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title